According to the Zhitong Finance App, Xiansheng Pharmaceutical (02096) announced that on October 13, 2026, the company spent HK$15.3431 million to repurchase 1,428,000 shares at a repurchase price of HK$10.5438-10.82 per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.